New York, NY, United States of America

Daniel Gilmer

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Gilmer

Introduction

Daniel Gilmer is a noteworthy inventor based in New York, NY, recognized for his significant contributions to the field of bacteriophage research. With a total of five patents to his name, Gilmer's work focuses on innovative methods to detect and treat gram-positive bacteria, a critical concern in the medical and biotechnology communities.

Latest Patents

Among his latest patents is a pioneering invention that provides methods, compositions, and articles of manufacture aimed at the prophylactic and therapeutic treatment of gram-positive bacteria. His work emphasizes the use of derived bacteriophage lysins, particularly PlySs2 and PlySs1 lytic enzymes, along with their variants and truncations. These inventions not only contribute to medical science but also hold the potential for significant advancements in treating bacterial infections in humans.

Career Highlights

Currently, Daniel Gilmer is associated with The Rockefeller University, where he applies his expertise in the field of bacteriophage technology and antibiotic resistance. His innovative approach has positioned him as a leading figure in this specialized area of research, focusing on developing effective solutions against pathogenic bacteria.

Collaborations

Daniel has collaborated with notable scientists, including Vincent A. Fischetti and Jonathan Schmitz. These partnerships enhance the collective knowledge and research outputs in the realm of bacteriophage lysins and their applications, fostering a collaborative environment that stimulates scientific progress.

Conclusion

In summary, Daniel Gilmer's inventive work has made a significant impact on the medical and scientific community, particularly in the fight against gram-positive bacteria. Through his patents and collaborations, he continues to contribute valuable insights and innovations that drive advancements in health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…